CAMBRIDGE, Mass. and BIRMINGHAM, Ala., Dec. 8, 2023 /PRNewswire/ -- Alveolus Bio today announced a strategic scientific collaboration with BiomEdit, an emerging animal health biotechnology company ...
Alveolus, a developer of non-vascular stents, is preparing to commercialize its products and will do so with more than $10 million in new financing. The Charlotte-based company said Thursday morning ...
Through this collaboration, Shilpa Biologics, the biologics arm of Shilpa Medicare, will become Alveolus Bio's exclusive global development and manufacturing partner. This partnership propels Alveolus ...
Researchers from Children's Hospital of Philadelphia (CHOP) have determined what happens at a cellular level as the lung alveolus forms and allows newborns to breathe air. Understanding this process ...
Editor’s note: Charlotte Beat is a regular feature on Wednesdays.There are thousands and thousands of people walking around today thanks to stent technology, small metallic devices that keep hollow ...
, a company focused on development of non-vascular stent technology, has another $15 million in the bank. The Charlotte-based medical device firm, which was launched in 2001, has now raised more than ...
The biomimetic lung unit model, comprising a biomimetic membrane, vascular cells, and pulmonary cells, can mimic respiration and cultivate cells at the air-liquid interface. The biomimetic membrane, ...
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, AL, has received a strategic financing round led by the ...
CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 /PRNewswire/ -- Alveolus Bio , a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback